109 related articles for article (PubMed ID: 29990695)
1. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
2. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
Ma L; Cai YJ; Yu L; Feng JY; Wang J; Li C; Niu JQ; Jiang YF
Antimicrob Agents Chemother; 2013 Mar; 57(3):1304-11. PubMed ID: 23274669
[TBL] [Abstract][Full Text] [Related]
3. Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets.
Ji L; Wei J; Zhang R; Zhang X; Gao Y; Fang M; Yu Z; Cao L; Gao Y; Li M
J Ethnopharmacol; 2024 Jun; 328():118072. PubMed ID: 38508431
[TBL] [Abstract][Full Text] [Related]
4. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection.
Zhang L; Jiang T; Yang Y; Deng W; Lu H; Wang S; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Yang L; Bi X; Lin Y; Lu Y; Jiang Y; Li M; Xie Y
Front Immunol; 2022; 13():1112234. PubMed ID: 36685527
[TBL] [Abstract][Full Text] [Related]
5. Effect of viral load on T-lymphocyte failure in patients with chronic hepatitis B.
You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Chen HY; Yu L; Tang BZ; Huang JH
World J Gastroenterol; 2008 Feb; 14(7):1112-9. PubMed ID: 18286696
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 modulates balance between regulatory T cells and T-helper 17 cells in chronic hepatitis B virus infection.
Cai Y; Ji H; Zhou X; Zhao K; Zhang X; Pan L; Shi R
BMC Infect Dis; 2023 Oct; 23(1):719. PubMed ID: 37875903
[TBL] [Abstract][Full Text] [Related]
7. A mutual regulatory loop between transcription factor Yin Yang 1 and hepatitis B virus replication influences chronic hepatitis B.
Zhou J; Hua Y; Liu Y; Wu T; Xu H; Wang Z; Wang X; Niu J
Antiviral Res; 2024 Jun; 226():105889. PubMed ID: 38631661
[TBL] [Abstract][Full Text] [Related]
8. High immunocompetence in chronic hepatitis patients with normal alanine transaminase levels and and negative hepatitis B e-antigen for the progression of liver fibrosis.
Cheng B; Wu D; Zhang M; Chen S; Wu X; Zhong J; Wu M; Huo M
Immun Inflamm Dis; 2024 Jan; 12(1):e1134. PubMed ID: 38270318
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane effectively inhibits HBV by altering Treg/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo.
Xu R; Wu Y; Xiang X; Lv X; He M; Xu C; Lai G; Xiang T
Virus Res; 2024 Mar; 341():199316. PubMed ID: 38215982
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection.
Mukherjee R; Reddy PB; Arava J; Rao P; Mitnala S; Gupta R; Reddy D
Hepat Med; 2010; 2():157-62. PubMed ID: 24367213
[TBL] [Abstract][Full Text] [Related]
11. The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal.
Liu Y; Qiu L; Wang Y; Aimurola H; Zhao Y; Li S; Xu Z
PLoS One; 2016; 11(2):e0148207. PubMed ID: 26845566
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.
You J; Zhuang L; Zhang YF; Chen HY; Sriplung H; Geater A; Chongsuvivatwong V; Piratvisuth T; McNeil E; Yu L; Tang BZ; Huang JH
World J Gastroenterol; 2009 Jul; 15(27):3382-93. PubMed ID: 19610139
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8
Takahama S; Yoshio S; Masuta Y; Murakami H; Sakamori R; Kaneko S; Honda T; Murakawa M; Sugiyama M; Kurosaki M; Asahina Y; Takehara T; Appay V; Kanto T; Yamamoto T
Front Immunol; 2023; 14():1257113. PubMed ID: 37920475
[TBL] [Abstract][Full Text] [Related]
14. CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus.
Andreata F; Moynihan KD; Fumagalli V; Di Lucia P; Pappas DC; Kawashima K; Ni I; Bessette PH; Perucchini C; Bono E; Giustini L; Nguyen HC; Chin SM; Yeung YA; Gibbs CS; Djuretic I; Iannacone M
Sci Transl Med; 2024 Jan; 16(729):eadi1572. PubMed ID: 38198572
[TBL] [Abstract][Full Text] [Related]
15. Potential role of Vitamin D in immune response in patients with viral hepatitis.
Gerhards C; Teufel A; Gerigk M; French M; Antoni C; Ebert M; Neumaier M; Evliyaoglu O
Nutrition; 2024 Mar; 124():112447. PubMed ID: 38669827
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
Chen X; Huang J; Huang Y; Chen J; Huang Y; Jiang X; Shi Y
Hum Immunol; 2020 Dec; 81(12):702-708. PubMed ID: 32950268
[TBL] [Abstract][Full Text] [Related]
17. Levels of interleukin-35 and its relationship with regulatory T-cells in chronic hepatitis B patients.
Shi YY; Dai MJ; Wu GP; Zhou PP; Fang Y; Yan XB
Viral Immunol; 2015 Mar; 28(2):93-100. PubMed ID: 25494369
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen seroclearance is uncommon but durable in the long run.
Yip TC; Brunetto MR
Hepatology; 2024 Jun; 79(6):1258-1260. PubMed ID: 38147302
[No Abstract] [Full Text] [Related]
19. CD56
Lee M; Bell CJM; Rubio Garcia A; Godfrey L; Pekalski M; Wicker LS; Todd JA; Ferreira RC
Discov Immunol; 2023; 2(1):kyad012. PubMed ID: 37649552
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B.
Shin H; Lee HS; Noh JY; Koh JY; Kim SY; Park J; Chung SW; Hur MH; Park MK; Lee YB; Kim YJ; Yoon JH; Ko JH; Peck KR; Song JY; Shin EC; Lee JH
Immune Netw; 2023 Oct; 23(5):e39. PubMed ID: 37970236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
